Skip to main content

Table 4 Bivariate analysis of factors associated with CVD mortality risk

From: Association of predicted 10 years cardiovascular mortality risk with duration of HIV infection and antiretroviral therapy among HIV-infected individuals in Durban, South Africa

Variables

Total (N = 144)

< 5.00%

5.00–9.90%

10.00–19.90%

20.00–29.90%

> 30.00%

P value

Black Africans

133

71 (53.38)

24 (18.05)

23 (17.29)

9 (6.77)

6 (4.51)

< 0.001Ϯ

Other racesα

11

4.0 (36.36)

2 (18.18)

5 (45.45)

1st line regimen

73

37 (50.68)

13 (17.81)

16 (21.92)

4 (5.48)

3 (4.11)

0.211*

2nd line regimen

70

37 (52.86)

13 (18.57)

7 (10)

5 (7.14)

8 (11.43)

Previous tuberculosis

70

44 (62.86)

8 (11.43)

11 (15.71)

4 (5.71)

3 (4.29)

0.063Ϯ

No tuberculosis

72

30 (41.67)

18 (25.00)

11 (15.28)

5 (6.94)

8 (11.11)

  1. ϮFisher’s exact test; * Pearson Chi square (χ2) test, α Coloured and White